These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 8496606)

  • 1. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle.
    Pemberton M; Anderson G; Vĕtvicka V; Justus DE; Ross GD
    J Immunol; 1993 Jun; 150(11):5104-13. PubMed ID: 8496606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of inhibition of complement by sCR1 on hepatic microcirculation after warm ischemia.
    Lehmann TG; Koeppel TA; Münch S; Heger M; Kirschfink M; Klar E; Post S
    Microvasc Res; 2001 Nov; 62(3):284-92. PubMed ID: 11678631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardium.
    Weisman HF; Bartow T; Leppo MK; Boyle MP; Marsh HC; Carson GR; Roux KH; Weisfeldt ML; Fearon DT
    Trans Assoc Am Physicians; 1990; 103():64-72. PubMed ID: 2132543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of immunosuppressants and steroids against ischemia-reperfusion injury in cremaster muscle flap at microcirculatory level.
    Askar I; Bozkurt M
    Microsurgery; 2002; 22(8):361-6. PubMed ID: 12497573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiinflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine.
    Eror AT; Stojadinovic A; Starnes BW; Makrides SC; Tsokos GC; Shea-Donohue T
    Clin Immunol; 1999 Feb; 90(2):266-75. PubMed ID: 10080839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective effects of selective inhibition of the two complement activation pathways in myocardial ischemia and reperfusion injury.
    Murohara T; Guo JP; Delyani JA; Lefer AM
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17(8):499-507. PubMed ID: 8749222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway.
    Scesney SM; Makrides SC; Gosselin ML; Ford PJ; Andrews BM; Hayman EG; Marsh HC
    Eur J Immunol; 1996 Aug; 26(8):1729-35. PubMed ID: 8765013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial and temporal correlation between leukocyte behavior and cell injury in postischemic rat skeletal muscle microcirculation.
    Suematsu M; DeLano FA; Poole D; Engler RL; Miyasaka M; Zweifach BW; Schmid-Schönbein GW
    Lab Invest; 1994 May; 70(5):684-95. PubMed ID: 7910874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease.
    Thrane AS; Skehan JD; Thrane PS
    Med Hypotheses; 2007; 68(6):1363-70. PubMed ID: 17169498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble complement receptor type 1 prevents human complement-mediated damage of the rabbit isolated heart.
    Homeister JW; Satoh PS; Kilgore KS; Lucchesi BR
    J Immunol; 1993 Feb; 150(3):1055-64. PubMed ID: 8423331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulsed acoustic cellular expression as a protective therapy against I/R injury in a cremaster muscle flap model.
    Krokowicz L; Klimczak A; Cwykiel J; Mielniczuk M; Grykien C; Siemionow M
    Microvasc Res; 2012 Mar; 83(2):213-22. PubMed ID: 22155420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.
    Teoh NC; Ito Y; Field J; Bethea NW; Amr D; McCuskey MK; McCuskey RS; Farrell GC; Allison AC
    Gastroenterology; 2007 Aug; 133(2):632-46. PubMed ID: 17681182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte-endothelium interaction in arterioles after ischemia and reperfusion.
    Liu X; Peter FW; Barker JH; Pierangeli SS; Harris EN; Anderson GL
    J Surg Res; 1999 Nov; 87(1):77-84. PubMed ID: 10527707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kappa-opioid receptor agonist protects the microcirculation of skeletal muscle from ischemia reperfusion injury.
    Lin JY; Hung LM; Lai LY; Wei FC
    Ann Plast Surg; 2008 Sep; 61(3):330-6. PubMed ID: 18724138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement inhibition by soluble complement receptor type 1 improves microcirculation after rat liver transplantation.
    Lehmann TG; Koeppel TA; Kirschfink M; Gebhard MM; Herfarth C; Otto G; Post S
    Transplantation; 1998 Sep; 66(6):717-22. PubMed ID: 9771834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of microvascular vasoconstriction following ischemia/reperfusion in skeletal muscle using videomicroscopy.
    Pemberton M; Anderson GL; Barker JH
    Microsurgery; 1996; 17(1):9-16. PubMed ID: 8892274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo analysis of microcirculation following closed soft-tissue injury.
    Schaser KD; Vollmar B; Menger MD; Schewior L; Kroppenstedt SN; Raschke M; Lübbe AS; Haas NP; Mittlmeier T
    J Orthop Res; 1999 Sep; 17(5):678-85. PubMed ID: 10569476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble complement receptor 1 preserves endothelial barrier function and microcirculation in postischemic pancreatitis in the rat.
    von Dobschuetz E; Bleiziffer O; Pahernik S; Dellian M; Hoffmann T; Messmer K
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G791-6. PubMed ID: 14693506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.
    De Vries B; Matthijsen RA; Wolfs TG; Van Bijnen AA; Heeringa P; Buurman WA
    Transplantation; 2003 Feb; 75(3):375-82. PubMed ID: 12589162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat.
    Pratt JR; Hibbs MJ; Laver AJ; Smith RA; Sacks SH
    Am J Pathol; 1996 Dec; 149(6):2055-66. PubMed ID: 8952538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.